Christopher Kyle, MD
Urology · Springfield, ORNPI 1205037587
Payments from drug & device makers
Across 60 payments — averaging $41.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neotract Inc.$1K
- Procept Biorobotics Corporation$522
- Johnson & Johnson$354
- Terumo Medical Corporation$98
- AbbVie$85
- Urogpo LLC$55
- plus $221 from 10 others
What the payments were for
- Travel & lodging$1,15347%
- Food & beverage$1,31553%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neotract Inc. | 6 | $1,138 |
| Procept Biorobotics Corporation | 6 | $522 |
| Johnson & Johnson | 25 | $354 |
| Terumo Medical Corporation | 1 | $98 |
| AbbVie | 4 | $85 |
| Urogpo LLC | 4 | $55 |
| EDAP Technomed Inc | 1 | $40 |
| AstraZeneca | 1 | $32 |
| Urogen Pharma, Inc. | 1 | $32 |
| Dendreon Pharmaceuticals LLC | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Novartis | 1 | $19 |
| Pfizer | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $4 |
| SN Holdings, LLC | 5 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$1,066
- AquaBeam Robotic System$402
How this compares
$2,472 in reported general payments places this provider in the 55th percentile of 153 urology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 49 | $30,615 |
| Tamsulosin Hcl | 551 | $9,893 |
| Solifenacin Succinate | 86 | $2,306 |
| Methenamine Hippurate | 29 | $1,976 |
| Finasteride | 146 | $1,835 |
| Testosterone Cypionate | 39 | $1,384 |
| Trospium Chloride | 18 | $1,255 |
| Silodosin | 16 | $802 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 30 | $747 |
| Potassium Citrate ErPotassium Citrate | 13 | $668 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 94 | $366 |
| Cephalexin | 29 | $320 |
| Oxycodone Hcl | 17 | $200 |
| Amikacin Sulfate | 11 | $196 |
| Oxybutynin Chloride | 13 | $100 |
Paid to pharmacies, not to this prescriber.
Other urology in Springfield
- Bryan MehlhaffSpringfield$10.4M
- David DimarcoSpringfield$75K
- Kevin KrughoffSpringfield$54K
- Dawn BodellSpringfield$4K
- Brenton SherwoodSpringfield$3K
- Brady WalkerSpringfield$3K
- Mark GarzottoPortland$2.3M
- Lance MarrPortland$323K
- Ryan KoppPortland$266K
- Jen-Jane LiuPortland$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.